Cargando…
Safety and efficacy of apatinib combined with iodine-125 in chemotherapy-refractory advanced lung cancer: A case report
INTRODUCTION: Apatinib is a novel anti-angiogenic agent that targets vascular endothelial growth factor receptor-2, and is effective in patients with advanced lung cancer who are refractory to first-line chemotherapy. However, there are limited reports on concurrent apatinib therapy with iodine-125...
Autores principales: | Zhang, Yunchao, Yin, Shiqiang, Jia, Yingjie, Qin, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437787/ https://www.ncbi.nlm.nih.gov/pubmed/32872014 http://dx.doi.org/10.1097/MD.0000000000021600 |
Ejemplares similares
-
Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021) -
Successful treatment of ovarian cancer with apatinib combined with chemotherapy: A case report
por: Zhang, Mingzi, et al.
Publicado: (2017) -
Feasibility of (125)I brachytherapy combined with arterial infusion chemotherapy in patients with advanced pancreatic cancer
por: Huang, Shujing, et al.
Publicado: (2023) -
Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis
por: Liu, Ying, et al.
Publicado: (2020) -
Survival of patients with advanced pancreatic cancer after iodine(125) seeds implantation brachytherapy: A meta-analysis
por: Han, Quanli, et al.
Publicado: (2017)